Dr. Chadi Nabhan delves into the realm of AI and its impact on drug development with Dr. Adam Petrich. Dr. Aaron Goodman joins Dr. Chadi Nabhan to discuss his latest issue with the ABIM's MOC program. Dr. Cordovano joins Dr. Nabhan to talk about how her wrongful diagnosis propelled her into patient advocacy. Dr. Bekaii-Saab, of the Mayo Clinic, joins Dr. Nabhan to delve into the most groundbreaking studies unveiled at the meeting. Investigative journalist Emily Le Coz joins Dr. Nabhan to share the story of a pharmacist's life claimed by burnout. Dr. Chadi Nabhan is joined by esteemed guests from the HoLISTIC consortium to discuss Hodgkin lymphoma. The fiery aftermath of Aaron Goodman's groundbreaking petition to dismantle the ABIM's MOC program takes center stage. Dr. Salma Jabbour joins Dr. Chadi Nabhan to provide her invaluable perspective on the PROSPECT trial findings. Dr. David Lankford joins Dr. Nabhan to discuss the complex world of noncompete clauses in the medical field. Dr. Robert Califf, FDA commissioner, discusses the Administration's contentious accelerated approval regulatory pathway. Drs. Hossein Borghaei and Tony Calles join Dr. Nabhan to dissect cutting-edge data from the ESMO Congress 2023. Steve Stavs, a “pro biohacker” and “health futurist,” talks about the benefits of Eastern medicine for overall ... Dr. Chadi Nabhan spoke with Ameish Govindarajan, MD, who shared his experience as a patient diagnosed with stage 4 NSCLC. Dr. Chadi Nabhan and experts discuss the intricate relationship between the microbiome and cancer. Dr. Allison Rosenthal talks about her leukemia survivorship journey and how she advocates for AYA patients with cancer. Dr. Clifford Hudis, CEO of ASCO, discusses ASCO's approach to addressing the continuing saga of the ABIM's MOC program. Drs. Chadi Nabhan and Jennifer Mack discuss the delicate art of delivering bad news to patients with cancer. Moshe Chasky and Allen Lord Terzian, of Alliance Cancer Specialists, join Dr. Chadi Nabhan to discuss a high-stakes lawsuit. Dr. Chadi Nabhan is joined by the ASH president and chair of communications to discuss their position on MOC. Shelly Rosenfeld discusses the intersection between medical and legal concerns in cancer care.